Corporate Compliance

OIG reviews Medicaid outpatient drug expenditures in Montana

Healthcare Auditing Weekly, January 29, 2008

A small percentage of Medicaid outpatient drug expenditures in Montana for fiscal years 2002 through 2004 were not eligible for Medicaid coverage, an OIG audit found.

Of the $198 million claimed for reimbursement, $992,440 was for drugs that did not meet the requirements for reimbursement. They were either terminated drugs for which the termination dates were listed on the CMS quarterly drug tape before the drugs were dispensed or inadequately supported compound drug expenditures. An additional $363,210 represents expenditures for drug products that were not listed on the quarterly drug tapes and may not have been eligible for Medicaid coverage.

The OIG recommended Montana's Medicaid agency:

  • Refund $992,440 to the federal government for drug expenditures that were not eligible for Medicaid coverage
  • Work with CMS to resolve $363,210 in payments for drugs that were not listed on the quarterly drug tapes
  • Strengthen internal controls to ensure that claimed Medicaid drug expenditures comply with federal requirements

Comments

0 comments on “OIG reviews Medicaid outpatient drug expenditures in Montana

 

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

  • Medicare Update for Physician Services

    Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...

Most Popular

Related Articles